Open Application
Pipeline listing This is a talent pool for possible future openings, not a job that is currently open. Applying adds you to the employer's pipeline.
This is the employer's own posting, not a copy on a job board.
What we know
Is it still open?
Confirmed still open
Last checked 2d ago — checked against the employer's own applicant tracking system, which is the company answering directly.
We re-read the employer's own applicant tracking system and the posting was still there. That is the company answering directly.
How old is it?
Posted 103d ago
The date the source published, not the day we noticed it (2026-06-29). Last seen at its source 2h ago.
We have tracked this listing since 5 Oct 2026 (5 days). The employer's own board has carried it every time we have read it, most recently 2 hours ago.
Is it remote?
Remote
That is the location the employer filed this posting under. Quoted as written — we do not re-word the source's own location.
Who may apply?
Not stated
The description states no restriction of its own. This is the source's own tag.
Skills named in the ad
Recognised terms only, from a fixed vocabulary — this is what CV matching compares against.
Carried by 1 source
-
Ashby employer's own board first seen 5d ago · last seen 2h ago
The listing
All are welcome.
Here are some of Outro’s core tasks, missions and objectives:
Build the category of deprescribing.
Bring integrity back to medicine, where decades of pharmaceutical influence have led to the overprescribing of America.
Operate with high levels of accuracy, integrity and creativity.
Prove that it’s possible to build a massive, profitable company that does right by science and by people.
Build (maybe) the first company that is defined be selling people less stuff.
Outro Health is the first company dedicated to helping people feel better by using less medication, rather than more.
Our flagship program, Taper Management, is a virtual care program that helps people safely taper off antidepressants and other psychiatric medications. It’s based on hyperbolic tapering, the first neurobiology-based method for stopping psychiatric medications.
We’ve built the best team in the budding field of deprescribing, led by our co-founder Dr. Mark Horowitz—the world-leading expert in the space. Dr. Horowitz literally wrote the textbook on deprescribing, and has helped update national guidelines in several countries.
In our first year in market, we've developed a first-of-its-kind care model, generating meaningful revenue with healthy economics, and even establishing research partnerships with leading health systems and universities. The next phase is about model refinement, patient delight, and scale.
More on Outro here: